Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Sell
489,503
-212
-0% -$5.64K 0.06% 177
2025
Q4
$12.2M Sell
489,715
-358,183
-42% -$9.03M 0.05% 180
2025
Q3
$21.6M Sell
847,898
-49,682
-6% -$1.23M 0.1% 145
2025
Q2
$21.8M Sell
897,580
-213,583
-19% -$4.98M 0.1% 147
2025
Q1
$28.2M Sell
1,111,163
-64,681
-6% -$1.69M 0.15% 135
2024
Q4
$31.2M Sell
1,175,844
-87,667
-7% -$2.38M 0.16% 131
2024
Q3
$36.6M Buy
1,263,511
+39,670
+3% +$1.16M 0.19% 127
2024
Q2
$34.2M Buy
1,223,841
+76,464
+7% +$2.11M 0.19% 123
2024
Q1
$41.6M Buy
1,147,377
+146,126
+15% +$4.05M 0.23% 120
2023
Q4
$28.8M Buy
1,001,251
+791,452
+377% +$23.9M 0.17% 135
2023
Q3
$6.96M Sell
209,799
-7,784
-4% -$275K 0.05% 220
2023
Q2
$7.98M Sell
217,583
-393,232
-64% -$15.3M 0.06% 210
2023
Q1
$24.9M Buy
610,815
+3,123
+0.5% +$135K 0.17% 136
2022
Q4
$31.1M Buy
+607,692
New +$29.1M 0.23% 117

Other funds holding PFE

AGF Management's PFE Position: Q1 2026 in Review

AGF Management reduced its Pfizer (PFE) stake by 0.04% in Q1 2026, selling an estimated $5.64K and leaving 489,503 shares worth $13.7M. The position accounts for 0.06% of the portfolio, ranked #177.

AGF Management first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $41.6M in Q1 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AGF Management held 489,503 shares of Pfizer worth $13.7M as of Q1 2026.
  • AGF Management sold 212 Pfizer shares in Q1 2026, an estimated $5.64K.
  • Pfizer made up 0.06% of AGF Management's portfolio in Q1 2026, its #177 holding.
  • AGF Management first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • AGF Management's Pfizer position peaked at $41.6M in Q1 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.